We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




AI-Powered Cervical Cell Analysis System Aids Early Cancer Detection

By LabMedica International staff writers
Posted on 27 Oct 2023

A novel cervical cell analysis product helps overcome the limitations of Human Papillomavirus (HPV) testing by offering detailed insights into the stages of cervical pre-cancer and cancer, using cervical cytology as a screening method. More...

Noul Co., Ltd. (Yongin, South Korea) launched its miLab Cartridge CER, a specialized device for automatically staining and evaluating cervical cells. The cervical cell analysis product works on samples from cervico-vaginal smears, either manually prepared or using liquid-based cytology (LBC). It employs the Papanicolaou staining method, enhanced by Next Generation Staining and Immunostaining (NGSI), a proprietary staining technology developed by Noul. When paired with Noul's AI-driven diagnostic system, miLab, it provides staining, imaging, and cellular analysis results that aid in making diagnostic decisions.

The miLab Cartridge CER leverages cervical cytology for screening and is capable of identifying the detailed stages of cervical pre-cancer and cancer. This is achieved through AI-based morphological analysis, a key advantage offered by the miLab platform. Additionally, the product speeds up the total time for testing, making it easier for users to survey the entire sample area, differentiate between cells that are negative or positive for cancer, and focus on the cells most relevant for diagnosis. Noul received the CE mark for the miLab Cartridge CER in August 2022 and the CE-IVDR certification for the miLab platform in February 2023.

"Through the launch of cervical cell analysis products, we have made a real step forward in the cancer diagnostic business,” said David Lim, CEO of Noul. “The miLab Cartridge CER is compatible with both PAP smear and LBC methods, and it enables efficient and accurate cervical cell review with the full automatic staining and analysis. We want to contribute to the early diagnosis of cervical cancer, the fourth largest cancer in the world for women."

Related Links:
Noul Co., Ltd. 


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
Gold Member
Thyroid-Stimulating Hormone Test
ULTRA-TSH
New
Respiratory Infections Test
STANDARD Q Adeno Respi Ag Test
New
mRNA Extraction Kits
TurboCapture mRNA Kits
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Molecular Diagnostics

view channel
Image: The new study findings emphasize the need for incorporating disease heterogeneity into type 2 diabetes care strategies (Photo courtesy of Cell 2025; doi.org/10.1016/j.cell.2025.05.00)

Molecular Fingerprint for Insulin Sensitivity Could Diagnose Diabetes Before Disease Develops

Insulin is a hormone essential for regulating blood sugar levels, and its dysfunction is a key factor in the development of diabetes. Insulin resistance, a condition where the body's cells do not respond... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Technology

view channel
Image: Concept of biosensor integrated into hygiene pads enabling direct semi-quantitative analysis of biomarkers in unprocessed menstruation blood (Photo courtesy of Dosnon, L et al. DOI: 10.1002/advs.202505170)

First Ever Technology Recognizes Disease Biomarkers Directly in Menstrual Blood in Sanitary Towels

Over 1.8 billion people menstruate worldwide, yet menstrual blood has been largely overlooked in medical practice. This blood contains hundreds of proteins, many of which correlate with their concentration... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.